Human Edge builds a proprietary platform that generates personalized, actionable "biohack" prescriptions combining assessments, blood panels and real-time streams from consumer wearables. The company aggregates that data into a composite healthspan metric called the Human Edge Index and delivers daily, science-backed lifestyle interventions focused on energy optimization. Founded by Dr. Marcus Ranney in late 2020, Human Edge targets both consumer engagement and enterprise use cases. The company is preparing its first enterprise-wide mobile app experience targeted at white-collar employees. Management plans to use new funding to streamline the platform and scale international sales to global corporations. The article notes the global biohacking market stands at over $15 billion and is growing at an expected CAGR of 19 percent.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2022